Pappas TC

No ORCID on file · 3 papers in corpus · active 2023-2024
2024
Frontiers in medicine ·doi:10.3389/fmed.2024.1374836

BackgroundSurgery remains the main treatment option for an adnexal mass suspicious of ovarian cancer. The malignancy rate is, however, only 10-15% in women undergoing surgery. This results in a high number of unnecessary surgeries. A survei…

2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.08.008

ObjectiveTo determine whether a multimodal assay combining serum microRNA with protein biomarkers and metadata improves triage assessment of an adnexal mass.MethodsSerum samples from 468 training subjects (191 cancer cases and 277 benign ad…

2023
Frontiers in medicine ·doi:10.3389/fmed.2023.1102437

BackgroundConservative management of adnexal mass is warranted when there is imaging-based and clinical evidence of benign characteristics. Malignancy risk is, however, a concern due to the mortality rate of ovarian cancer. Malignancy occur…